Skip to main content
. 2022 Dec 5;25(12):e26043. doi: 10.1002/jia2.26043

Table 1.

Comparison in clinical differences in individuals with mpox, according to HIV status

Source

Number of PLWH

n/total (%)

Median CD4 cell count (IQR), /μl

PLWH with viral load > 200 copies/ml

n/total (%)

Differences between PLWH and HIV‐negative individuals with mpox
Tarín‐Vicente et al. [6] 72/181 (40) na (8/72 had a CD4 cell count <500) na No differences in clinical severity or disease progression
Thornhill et al. [7] 218/528 (41) 680 (513–861) 5/190 (3)

Similar clinical presentations

No differences in the frequency of hospitalization

Hoffmann et al. [8] 256/546 (47) 691 (185–1603) a (7/244 had a CD4 cell count <350) 4/236 (2) No differences in clinical presentation or hospitalization rates
Angelo et al. [9] 92/226 (41) 713 (500–885) (1/92 had a CD4 cell count <200) 7/83 (8) PLWH more likely to present with diarrhoea and perianal rash with a higher lesion burden
Curran et al. [10] 755/1969 (38) 639 (452–831) (25/755, 3% had a CD4 cell count <200) 137/755 (18) PLWH were more likely to report rectal pain, tenesmus and proctitis
Ogoina et al. [12] 9/40 (22) b na (at least 7/9 had a CD4 cell count <350) > 5/9 (>55) PLWH were more likely to have skin rashes ≥2 cm, genital ulcers, secondary bacterial skin infection and longer duration of illness
Silva et al. [13] 109/205 (53) 527 (379–827) 8/87 (9) PLWH were older, had higher prevalence of HCV coinfection, anal lesions and clinical features of proctitis
Miller et al. [14] 47/57 (82) b na (40/43 had a CD4 cell count <200) > 43/47 (>92) Hospitalized PLWH with severe mpox were mostly not on cART and with low CD4 count. In 5/12 deaths reported, mpox was the cause of death or a contributing factor

Abbreviations: IQR, interquartile range; PLWH, people living with HIV.

a

Range.

b

All patients were hospitalized.